Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Biologics Formulation Summit Highlights Best Practices

By Drug Discovery Trends Editor | May 23, 2014

Freeslate Inc., a provider of high throughput research solutions for biopharmaceutical development, announced highlights of its Biologics Formulation Summit held at Janssen Pharmaceutical in Malvern, Pennsylvania. The meeting featured a tour of the Janssen high throughput lab, customer case studies, and discussions of best practices in high throughput research and data management.
 
At this year’s Biologics Formulation Summit, scientists gathered to discuss the challenges and opportunities of formulation development and bring knowledge about best practices back to their organizations. The summit consisted of case-study presentations by a diverse set of customers including Janssen Pharmaceutical, Novo Nordisk, KBI Biopharma, and Amgen, who highlighted their experience with Freeslate products to achieve dramatic innovation and rapid return on investment. Hands-on training sessions were given by Freeslate staff who focused on accelerating productivity. A tour of the Janssen facilities allowed attendees to see automation tools at work and discuss specific implementation with scientists and technicians. Networking between sessions and at evening events offered opportunities for one-on-one discussion and exchanging of new strategies and ideas.
 
“Developing biologic drug products has always been a complex challenge, and today, the demands placed on development organizations are only increasing,” said John Senaldi, president and CEO of Freeslate. “We’re pleased that we can support leaders in biologics formulation coming together to have an open dialogue on the challenges and opportunities for making dramatic improvements in their productivity.”
 
Formulation development labs are under growing pressure to increase productivity due to a number of factors: an increasing number of biologics candidates, implementation of Quality by Design (QbD) initiatives requiring a broader understanding of the formulation design space, and reduced available resources. All these factors are pushing formulation chemists to achieve significant productivity gains. Freeslate is the leader in high throughput research solutions for drug development. Through collaborations with pharmaceutical/biotechnology R&D organizations, Freeslate has developed a unique high throughput research approach to address the challenges in biologics formulation. 
 
Date: May 22, 2014
Source: Freeslate

Filed Under: Drug Discovery

 

Related Articles Read More >

If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
Roche Towers, Basel, Switzerland
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE